CN Stock MarketDetailed Quotes

Innovative Medical Management (002173)

Watchlist
  • 24.37
  • +0.47+1.97%
Market Closed May 7 15:00 CST
10.75BMarket Cap-234.33P/E (TTM)

Innovative Medical Management (002173) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
-13.80%166.66M
-4.26%781.25M
-2.11%597.5M
-1.60%401.53M
-3.98%193.33M
1.30%816.02M
0.53%610.4M
0.67%408.04M
-1.40%201.34M
13.51%805.59M
Operating revenue
-13.80%166.66M
-4.26%781.25M
-2.11%597.5M
-1.60%401.53M
-3.98%193.33M
1.30%816.02M
0.53%610.4M
0.67%408.04M
-1.40%201.34M
13.51%805.59M
Other operating revenue
----
-21.63%3.04M
----
82.42%1.09M
----
128.89%3.88M
----
-2.91%598.49K
----
24.34%1.69M
Total operating cost
-6.08%192.75M
-2.61%852.87M
-1.24%628.5M
-0.69%414.19M
1.48%205.24M
5.70%875.72M
3.73%636.37M
4.05%417.09M
-0.51%202.24M
4.31%828.48M
Operating cost
-7.66%162.52M
-3.33%727.28M
-2.18%537.28M
-1.89%353.12M
-0.35%176.01M
5.46%752.33M
3.93%549.24M
3.75%359.94M
0.84%176.62M
5.05%713.38M
Operating tax surcharges
4.97%2.72M
-3.45%10.83M
-4.17%8.06M
-6.79%5.34M
-19.93%2.59M
14.76%11.22M
75.64%8.41M
79.61%5.73M
96.99%3.24M
48.19%9.78M
Operating expense
60.99%3.46M
-12.37%8.22M
-5.85%7.39M
15.16%4.76M
9.64%2.15M
-8.94%9.38M
0.35%7.85M
-20.15%4.14M
-36.19%1.96M
-14.78%10.3M
Administration expense
-8.67%22.29M
-2.54%102.84M
-2.41%74.6M
-0.88%50.61M
7.17%24.4M
-2.05%105.52M
-7.83%76.44M
-3.47%51.06M
-15.71%22.77M
0.93%107.73M
Financial expense
-104.83%-3.74K
121.95%597.54K
110.89%605.49K
109.55%360.26K
103.30%77.47K
78.56%-2.72M
47.24%-5.56M
48.54%-3.77M
34.75%-2.35M
-23.75%-12.7M
-Interest expense (Financial expense)
-2.73%673.3K
-6.74%3.82M
4.37%2.14M
6.13%1.89M
5.02%692.17K
12.15%4.09M
-6.54%2.05M
18.72%1.78M
-19.78%659.07K
8.86%3.65M
-Interest Income (Financial expense)
-22.83%-1.32M
44.66%-4.38M
66.97%-3.07M
65.53%-2.1M
69.51%-1.08M
54.55%-7.92M
31.24%-9.31M
35.06%-6.08M
24.56%-3.54M
-19.53%-17.42M
Research and development
--1.76M
--3.11M
--567.68K
----
----
----
----
----
----
----
Credit Impairment Loss
162.59%673.66K
261.54%3.96M
166.40%2.63M
171.50%3.42M
21.80%-1.08M
9.68%-2.45M
6.09%-3.96M
-39.85%-4.78M
-33.33%-1.38M
-226.79%-2.71M
Asset Impairment Loss
---150.36K
-460.78%-1.15M
----
----
----
67.08%-205.59K
-238.41%-88.31K
-239.83%-88.31K
----
52.66%-624.51K
Other net revenue
100.65%10.51K
6,552.26%41.05M
1,837.96%37.96M
173.11%4.07M
-33.08%-1.61M
76.84%-636.19K
39.10%-2.18M
-103.41%-5.57M
-5.26%-1.21M
-146.06%-2.75M
Fair value change income
-59.80%511.85K
-24.58%4.77M
60.88%4.21M
881.16%2.73M
537.00%1.27M
7,956.48%6.33M
--2.62M
--278.67K
--199.88K
--78.55K
Invest income
43.13%-1.19M
839.53%32.16M
1,650.96%29.51M
-132.31%-2.6M
-540.25%-2.1M
-126.86%-4.35M
-26.56%-1.9M
-22.83%-1.12M
44.47%-327.7K
-156.28%-1.92M
-Including: Investment income associates
43.16%-1.19M
138.31%1.52M
65.87%-889.99K
-55.25%-2.83M
-140.17%-2.1M
-49.92%-3.96M
-53.36%-2.61M
-64.67%-1.82M
-46.26%-873.59K
-39.28%-2.64M
Asset deal income
----
101.10%15.64K
102.21%13.84K
102.21%13.84K
----
-234.21%-1.42M
-159.00%-625.41K
-162.66%-625.41K
----
191.74%1.06M
Other revenue
-41.41%168.53K
-10.95%1.3M
-10.49%1.59M
-35.32%497.03K
-1.38%287.66K
6.85%1.46M
75.32%1.78M
44.48%768.42K
-19.46%291.68K
-52.78%1.37M
Operating profit
-92.90%-26.08M
49.33%-30.57M
124.69%6.95M
41.19%-8.59M
-540.02%-13.52M
-135.31%-60.33M
-183.85%-28.15M
-948.64%-14.61M
-838.87%-2.11M
67.38%-25.64M
Add:Non operating Income
-62.66%5.44K
553.33%15.62M
-69.23%1.61M
-77.99%1.12M
-81.33%14.56K
-55.00%2.39M
-19.08%5.24M
108.31%5.1M
-87.90%77.99K
-85.26%5.31M
Less:Non operating expense
-3.13%414.9K
-67.36%13.93M
-41.26%3.58M
-44.11%3.1M
-67.17%428.32K
191.66%42.69M
-22.87%6.09M
-5.34%5.54M
-54.22%1.3M
-55.28%14.64M
Total profit
-90.11%-26.49M
71.30%-28.88M
117.19%4.99M
29.80%-10.57M
-317.28%-13.93M
-187.82%-100.63M
-155.75%-29.01M
-793.67%-15.05M
-37.40%-3.34M
53.55%-34.96M
Less:Income tax cost
-218.54%-134.8K
210.90%7.37M
124.19%316.84K
-25.00%622.7K
88.23%-42.32K
-882.38%-6.65M
-144.93%-1.31M
-54.38%830.26K
-7.57%-359.44K
59.86%-676.55K
Net profit
-89.72%-26.35M
61.43%-36.26M
116.86%4.67M
29.54%-11.19M
-366.20%-13.89M
-174.11%-93.99M
-94.27%-27.7M
-353.25%-15.89M
-42.15%-2.98M
53.41%-34.29M
Net profit from continuing operation
-89.72%-26.35M
61.43%-36.26M
116.86%4.67M
29.54%-11.19M
-366.20%-13.89M
-174.11%-93.99M
-94.27%-27.7M
-353.25%-15.89M
-42.15%-2.98M
53.41%-34.29M
Less:Minority Profit
-2,673.59%-1.2M
-3,990.94%-1.4M
-138.05%-56.04K
17.25%169.37K
2,855.51%46.75K
-6,121.89%-34.24K
450.41%147.29K
383.42%144.44K
-102.66%-1.7K
99.68%-550.35
Net profit of parent company owners
-80.45%-25.15M
62.90%-34.85M
116.97%4.72M
29.12%-11.36M
-368.03%-13.94M
-174.02%-93.95M
-95.88%-27.84M
-364.12%-16.03M
-37.87%-2.98M
53.30%-34.29M
Earning per share
Basic earning per share
-100.00%-0.06
61.90%-0.08
116.67%0.01
25.00%-0.03
-347.76%-0.03
-162.50%-0.21
-88.09%-0.06
-400.00%-0.04
-39.58%-0.0067
50.00%-0.08
Diluted earning per share
-100.00%-0.06
61.90%-0.08
116.67%0.01
25.00%-0.03
-347.76%-0.03
-162.50%-0.21
-88.09%-0.06
-400.00%-0.04
-39.58%-0.0067
50.00%-0.08
Other composite income
Total composite income
-89.72%-26.35M
61.43%-36.26M
116.86%4.67M
29.54%-11.19M
-366.20%-13.89M
-174.11%-93.99M
-94.27%-27.7M
-353.25%-15.89M
-42.15%-2.98M
53.41%-34.29M
Total composite income of parent company owners
-80.45%-25.15M
62.90%-34.85M
116.97%4.72M
29.12%-11.36M
-368.03%-13.94M
-174.02%-93.95M
-95.88%-27.84M
-364.12%-16.03M
-37.87%-2.98M
53.30%-34.29M
Total composite income of minority owners
-2,673.59%-1.2M
-3,990.94%-1.4M
-138.05%-56.04K
17.25%169.37K
2,855.51%46.75K
-6,121.89%-34.24K
450.41%147.29K
383.42%144.44K
-102.66%-1.7K
99.68%-550.35
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue -13.80%166.66M-4.26%781.25M-2.11%597.5M-1.60%401.53M-3.98%193.33M1.30%816.02M0.53%610.4M0.67%408.04M-1.40%201.34M13.51%805.59M
Operating revenue -13.80%166.66M-4.26%781.25M-2.11%597.5M-1.60%401.53M-3.98%193.33M1.30%816.02M0.53%610.4M0.67%408.04M-1.40%201.34M13.51%805.59M
Other operating revenue -----21.63%3.04M----82.42%1.09M----128.89%3.88M-----2.91%598.49K----24.34%1.69M
Total operating cost -6.08%192.75M-2.61%852.87M-1.24%628.5M-0.69%414.19M1.48%205.24M5.70%875.72M3.73%636.37M4.05%417.09M-0.51%202.24M4.31%828.48M
Operating cost -7.66%162.52M-3.33%727.28M-2.18%537.28M-1.89%353.12M-0.35%176.01M5.46%752.33M3.93%549.24M3.75%359.94M0.84%176.62M5.05%713.38M
Operating tax surcharges 4.97%2.72M-3.45%10.83M-4.17%8.06M-6.79%5.34M-19.93%2.59M14.76%11.22M75.64%8.41M79.61%5.73M96.99%3.24M48.19%9.78M
Operating expense 60.99%3.46M-12.37%8.22M-5.85%7.39M15.16%4.76M9.64%2.15M-8.94%9.38M0.35%7.85M-20.15%4.14M-36.19%1.96M-14.78%10.3M
Administration expense -8.67%22.29M-2.54%102.84M-2.41%74.6M-0.88%50.61M7.17%24.4M-2.05%105.52M-7.83%76.44M-3.47%51.06M-15.71%22.77M0.93%107.73M
Financial expense -104.83%-3.74K121.95%597.54K110.89%605.49K109.55%360.26K103.30%77.47K78.56%-2.72M47.24%-5.56M48.54%-3.77M34.75%-2.35M-23.75%-12.7M
-Interest expense (Financial expense) -2.73%673.3K-6.74%3.82M4.37%2.14M6.13%1.89M5.02%692.17K12.15%4.09M-6.54%2.05M18.72%1.78M-19.78%659.07K8.86%3.65M
-Interest Income (Financial expense) -22.83%-1.32M44.66%-4.38M66.97%-3.07M65.53%-2.1M69.51%-1.08M54.55%-7.92M31.24%-9.31M35.06%-6.08M24.56%-3.54M-19.53%-17.42M
Research and development --1.76M--3.11M--567.68K----------------------------
Credit Impairment Loss 162.59%673.66K261.54%3.96M166.40%2.63M171.50%3.42M21.80%-1.08M9.68%-2.45M6.09%-3.96M-39.85%-4.78M-33.33%-1.38M-226.79%-2.71M
Asset Impairment Loss ---150.36K-460.78%-1.15M------------67.08%-205.59K-238.41%-88.31K-239.83%-88.31K----52.66%-624.51K
Other net revenue 100.65%10.51K6,552.26%41.05M1,837.96%37.96M173.11%4.07M-33.08%-1.61M76.84%-636.19K39.10%-2.18M-103.41%-5.57M-5.26%-1.21M-146.06%-2.75M
Fair value change income -59.80%511.85K-24.58%4.77M60.88%4.21M881.16%2.73M537.00%1.27M7,956.48%6.33M--2.62M--278.67K--199.88K--78.55K
Invest income 43.13%-1.19M839.53%32.16M1,650.96%29.51M-132.31%-2.6M-540.25%-2.1M-126.86%-4.35M-26.56%-1.9M-22.83%-1.12M44.47%-327.7K-156.28%-1.92M
-Including: Investment income associates 43.16%-1.19M138.31%1.52M65.87%-889.99K-55.25%-2.83M-140.17%-2.1M-49.92%-3.96M-53.36%-2.61M-64.67%-1.82M-46.26%-873.59K-39.28%-2.64M
Asset deal income ----101.10%15.64K102.21%13.84K102.21%13.84K-----234.21%-1.42M-159.00%-625.41K-162.66%-625.41K----191.74%1.06M
Other revenue -41.41%168.53K-10.95%1.3M-10.49%1.59M-35.32%497.03K-1.38%287.66K6.85%1.46M75.32%1.78M44.48%768.42K-19.46%291.68K-52.78%1.37M
Operating profit -92.90%-26.08M49.33%-30.57M124.69%6.95M41.19%-8.59M-540.02%-13.52M-135.31%-60.33M-183.85%-28.15M-948.64%-14.61M-838.87%-2.11M67.38%-25.64M
Add:Non operating Income -62.66%5.44K553.33%15.62M-69.23%1.61M-77.99%1.12M-81.33%14.56K-55.00%2.39M-19.08%5.24M108.31%5.1M-87.90%77.99K-85.26%5.31M
Less:Non operating expense -3.13%414.9K-67.36%13.93M-41.26%3.58M-44.11%3.1M-67.17%428.32K191.66%42.69M-22.87%6.09M-5.34%5.54M-54.22%1.3M-55.28%14.64M
Total profit -90.11%-26.49M71.30%-28.88M117.19%4.99M29.80%-10.57M-317.28%-13.93M-187.82%-100.63M-155.75%-29.01M-793.67%-15.05M-37.40%-3.34M53.55%-34.96M
Less:Income tax cost -218.54%-134.8K210.90%7.37M124.19%316.84K-25.00%622.7K88.23%-42.32K-882.38%-6.65M-144.93%-1.31M-54.38%830.26K-7.57%-359.44K59.86%-676.55K
Net profit -89.72%-26.35M61.43%-36.26M116.86%4.67M29.54%-11.19M-366.20%-13.89M-174.11%-93.99M-94.27%-27.7M-353.25%-15.89M-42.15%-2.98M53.41%-34.29M
Net profit from continuing operation -89.72%-26.35M61.43%-36.26M116.86%4.67M29.54%-11.19M-366.20%-13.89M-174.11%-93.99M-94.27%-27.7M-353.25%-15.89M-42.15%-2.98M53.41%-34.29M
Less:Minority Profit -2,673.59%-1.2M-3,990.94%-1.4M-138.05%-56.04K17.25%169.37K2,855.51%46.75K-6,121.89%-34.24K450.41%147.29K383.42%144.44K-102.66%-1.7K99.68%-550.35
Net profit of parent company owners -80.45%-25.15M62.90%-34.85M116.97%4.72M29.12%-11.36M-368.03%-13.94M-174.02%-93.95M-95.88%-27.84M-364.12%-16.03M-37.87%-2.98M53.30%-34.29M
Earning per share
Basic earning per share -100.00%-0.0661.90%-0.08116.67%0.0125.00%-0.03-347.76%-0.03-162.50%-0.21-88.09%-0.06-400.00%-0.04-39.58%-0.006750.00%-0.08
Diluted earning per share -100.00%-0.0661.90%-0.08116.67%0.0125.00%-0.03-347.76%-0.03-162.50%-0.21-88.09%-0.06-400.00%-0.04-39.58%-0.006750.00%-0.08
Other composite income
Total composite income -89.72%-26.35M61.43%-36.26M116.86%4.67M29.54%-11.19M-366.20%-13.89M-174.11%-93.99M-94.27%-27.7M-353.25%-15.89M-42.15%-2.98M53.41%-34.29M
Total composite income of parent company owners -80.45%-25.15M62.90%-34.85M116.97%4.72M29.12%-11.36M-368.03%-13.94M-174.02%-93.95M-95.88%-27.84M-364.12%-16.03M-37.87%-2.98M53.30%-34.29M
Total composite income of minority owners -2,673.59%-1.2M-3,990.94%-1.4M-138.05%-56.04K17.25%169.37K2,855.51%46.75K-6,121.89%-34.24K450.41%147.29K383.42%144.44K-102.66%-1.7K99.68%-550.35
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More